TY - JOUR T1 - Association of COVID-19 vaccination with risks of hospitalization and mortality due to cardiovascular and other diseases: A study of the UK Biobank JF - medRxiv DO - 10.1101/2021.08.15.21262097 SP - 2021.08.15.21262097 AU - Yong Xiang AU - Yaning Feng AU - Jinghong Qiu AU - Hon-Cheong So Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/08/20/2021.08.15.21262097.abstract N2 - Background Vaccines for COVID-19 represent a breakthrough in the fight against the pandemic. However, worries about adverse effects have led to vaccine hesitancy in some people. On the other hand, as COVID-19 may be associated with a range of sequelae, it is possible that vaccines may protect against hospitalization and mortality of various diseases.Methods We leveraged a large prospective cohort, the UK-Biobank (UKBB), and studied associations of at least one dose of COVID-19 vaccination (BioNTech BNT162b2 or Oxford-AstraZeneca ChAdOx1 nCoV-19) with hospitalization and mortalities from cardiovascular and other diseases (N=180,727). Multivariable Cox and Poisson regression was conducted controlling for main confounders. For hospitalizations, we also conducted separate analysis for new-onset and recurrent cases. All-cause and cardiovascular mortality were also included as outcome.Results We observed that COVID-19 vaccination (at least one dose) was associated with lower risks of hospitalizations from stroke (hazard ratio [HR]=0.371, 95% CI: 0.254-0.543, p=3.36e-7), venous thromboembolism (VTE) (HR=0.485, 95% CI: 0.292-0.804, p=4.99e-3), dementia (HR=0.207, 95% CI 0.091-0.470; p=1.66e-4) and non-COVID-19 pneumonia (HR=0.482, 95% CI 0.313-0.742; p=9.18e-4). Regarding mortality, an association with lower all-cause and cardiovascular mortality was observed, as well as lower mortality from several diseases including stroke, coronary artery disease(CAD), and chronic obstructive pulmonary disease (COPD) and dementia. There is no evidence that vaccination was associated with increased hospitalization/fatality from any specific disorders.Conclusions Taken together, this study provides further support to the safety and benefits of COVID-19 vaccination, and such benefits may extend beyond reduction of infection risk or severity per se. As an observational study, causal relationship cannot be concluded and further studies are required to verify the findings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported partially a National Natural Science Foundation China (NSFC) grant (81971706), the Lo Kwee Seong Biomedical Research Fund from The Chinese University of Hong Kong and the KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research of Common Diseases, Kunming Institute of Zoology and The Chinese University of Hong Kong, China.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The UK Biobank study has received ethical approval from the NHS National Research Ethics Service North West (16/NW/0274).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesQualified researchers may apply for access to the UK Biobank, which contains individual-level data. Summary results are presented in main and supplementary tables. ER -